Gudasheva TA - Search Results

1

The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship.

Gudasheva TA, Deeva OA, Pantileev AS, Mokrov GV, Rybina IV, Yarkova MA, Seredenin SB. Gudasheva TA, et al. Molecules. 2020 Nov 4;25(21):5132. doi: 10.3390/molecules25215132. Molecules. 2020. PMID: 33158242 Free PMC article.

2

GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons.

Pelsman A, Hoyo-Vadillo C, Gudasheva TA, Seredenin SB, Ostrovskaya RU, Busciglio J. Pelsman A, et al. Among authors: gudasheva ta. Int J Dev Neurosci. 2003 May;21(3):117-24. doi: 10.1016/s0736-5748(03)00031-5. Int J Dev Neurosci. 2003. PMID: 12711349

3

Novel Technologies for Dipeptide Drugs Design and their Implantation.

Gudasheva TA, Ostrovskaya RU, Seredenin SB. Gudasheva TA, et al. Curr Pharm Des. 2018;24(26):3020-3027. doi: 10.2174/1381612824666181008105641. Curr Pharm Des. 2018. PMID: 30295186 Free PMC article. Review.

4

Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.

Gudasheva TA, Deeva OA, Mokrov GV, Dyabina AS, Yarkova MA, Seredenin SB. Gudasheva TA, et al. Med Chem. 2019;15(4):383-399. doi: 10.2174/1573406415666181119164846. Med Chem. 2019. PMID: 30457052

5

The Ligands of Translocator Protein: Design and Biological Properties.

Mokrov GV, Deeva OA, Gudasheva TA. Mokrov GV, et al. Among authors: gudasheva ta. Curr Pharm Des. 2021;27(2):217-237. doi: 10.2174/1381612826666200903122025. Curr Pharm Des. 2021. PMID: 32881658 Review.

6

Design, Synthesis and Pharmacological Activity of New Pyrrolo[1,2-A] Pyrazine Translocator Protein (TSPO) Ligands.

Mokrov G, Pantileev A, Yarkova M, Gudasheva T, Seredenin S. Mokrov G, et al. Med Chem. 2022;18(4):497-508. doi: 10.2174/1573406417666210806095051. Med Chem. 2022. PMID: 34365957

7

Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling.

Vakhitova YV, Kalinina TS, Zainullina LF, Lusta AY, Volkova AV, Kudryashov NV, Gudasheva TA, Shimshirt AA, Kadnikov IA, Voronin MV, Seredenin SB. Vakhitova YV, et al. Among authors: gudasheva ta. Int J Mol Sci. 2021 Dec 13;22(24):13381. doi: 10.3390/ijms222413381. Int J Mol Sci. 2021. PMID: 34948177 Free PMC article.

8

Low molecular weight NGF mimetic GK-2 normalizes the parameters of glucose and lipid metabolism and exhibits a hepatoprotective effect on a prediabetes model in obese Wistar rats.

Ivanov SV, Ostrovskaya RU, Koliasnikova KN, Alchinova IB, Demorzhi MS, Gudasheva TA, Seredenin SB. Ivanov SV, et al. Among authors: gudasheva ta. Clin Exp Pharmacol Physiol. 2022 Oct;49(10):1116-1125. doi: 10.1111/1440-1681.13693. Epub 2022 Jul 12. Clin Exp Pharmacol Physiol. 2022. PMID: 35748804

9

Neuroprotective Effect of the Neuropeptide Cycloprolylglycine Depends on AMPA- and TrkB-Receptor Activation.

Gudasheva TA, Koliasnikova KN, Alyaeva AG, Nikolaev SV, Antipova TA, Seredenin SB. Gudasheva TA, et al. Dokl Biochem Biophys. 2022 Dec;507(1):264-267. doi: 10.1134/S1607672922060047. Epub 2023 Feb 14. Dokl Biochem Biophys. 2022. PMID: 36786983

10

Design, Synthesis and Anticonvulsant Activity of Cinnamoyl Derivatives of 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1-(2H)-one Oxime.

Mokrov GV, Biryukova VE, Vorobieva TY, Pantileev AS, Grigorkevich OS, Zhmurenko LA, Rebeko AG, Bayburtskiy FS, Litvinova SA, Voronina TA, Gudasheva TA, Seredenin SB. Mokrov GV, et al. Among authors: gudasheva ta. Med Chem. 2024;20(1):92-107. doi: 10.2174/1573406419666230908121759. Med Chem. 2024. PMID: 37694795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters